Amicus Therapeutics US, LLC et al v. Lupin Ltd. et al
| Amicus Therapeutics US, LLC and Amicus Therapeutics, Inc. |
| Lupin Ltd., Lupin Pharmaceuticals, Inc. and Springcare USA LLC doing business as Spring Bio Solution |
| 1:2022cv01465 |
| November 7, 2022 |
| US District Court for the District of Delaware |
| Colm F Connolly |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on April 27, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
ORAL ORDER Setting Scheduling Conference:( An In-Person Scheduling Conference is set for 5/8/2023 at 02:30 PM in Courtroom 4B before Judge Colm F. Connolly. Ordered by Judge Colm F. Connolly on 4/27/2023. Associated Cases: 1:22-cv-01461-CFC, 1:22-cv-01462-CFC, 1:22-cv-01465-CFC, 1:22-cv-01467-CFC(nmf)
|
| Filing 29 PROPOSED ORDER regarding Scheduling Order by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: #1 Letter regarding Proposed Scheduling Order)(Stover, Chad) |
|
SO ORDERED, re (34 in 1:22-cv-01467-CFC) STIPULATION TO EXTEND TIME to Submit Proposed Scheduling Order to April 18, 2023 filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC, (28 in 1:22-cv-01465-CFC) STIPULATION TO EXTEND TIME to Submit Proposed Scheduling Order to April 18, 2023 filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC, (24 in 1:22-cv-01462-CFC) STIPULATION TO EXTEND TIME to Submit Proposed Scheduling Order to April 18, 2023 filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC, (24 in 1:22-cv-01461-CFC) STIPULATION TO EXTEND TIME to Submit Proposed Scheduling Order to April 18, 2023 filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC. Signed by Judge Colm F. Connolly on 4/10/2023. Associated Cases: 1:22-cv-01461-CFC, 1:22-cv-01462-CFC, 1:22-cv-01465-CFC, 1:22-cv-01467-CFC(nmf)
|
| Filing 28 STIPULATION TO EXTEND TIME to Submit Proposed Scheduling Order to April 18, 2023 - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Stover, Chad) |
| Filing 27 ANSWER to #17 Answer to Complaint, Counterclaim by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc..(Stover, Chad) |
| Filing 26 Letter to The Honorable Colm F. Connolly from Chad S.C. Stover regarding coordinated discovery and Markman proceedings - re (14 in 1:22-cv-01462-CFC, 14 in 1:22-cv-01462-CFC, 22 in 1:22-cv-01465-CFC, 22 in 1:22-cv-01465-CFC, 14 in 1:22-cv-01461-CFC, 14 in 1:22-cv-01461-CFC, 18 in 1:22-cv-01467-CFC, 18 in 1:22-cv-01467-CFC) Order,,, Set Deadlines,,. (Stover, Chad) |
|
Filing 25
SO ORDERED, re #24 STIPULATION TO EXTEND TIME to Respond to Counterclaims to February 17, 2023, filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC. Reset Answer Deadlines: Amicus Therapeutics US, LLC answer due 2/17/2023; Amicus Therapeutics, Inc. answer due 2/17/2023. Signed by Judge Colm F. Connolly on 1/25/2023. (kmd)
|
| Filing 24 STIPULATION TO EXTEND TIME to Respond to Counterclaims to February 17, 2023 - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Stover, Chad) |
| Filing 23 MOTION for Pro Hac Vice Appearance of Attorney Daniel E. Orr - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Stover, Chad) Modified on 1/19/2023 (kmd). |
|
SO ORDERED, re (23 in 1:22-cv-01465-CFC) (15 in 1:22-cv-01461-CFC) (19 in 1:22-cv-01467-CFC) (15 in 1:22-cv-01462-CFC) MOTION for Pro Hac Vice Appearance of Attorney Daniel E. Orr, filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC. Ordered by Judge Colm F. Connolly on 1/19/2023. Associated Cases: 1:22-cv-01465-CFC, 1:22-cv-01461-CFC, 1:22-cv-01462-CFC, 1:22-cv-01467-CFC(kmd)
|
| Pro Hac Vice Attorney Joshua E. Ney for Amicus Therapeutics US, LLC and Amicus Therapeutics, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:22-cv-01461-CFC, 1:22-cv-01462-CFC, 1:22-cv-01465-CFC, 1:22-cv-01467-CFC(mkr) |
| Pro Hac Vice Attorney Lauren Baker for Amicus Therapeutics US, LLC and Amicus Therapeutics, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:22-cv-01461-CFC, 1:22-cv-01462-CFC, 1:22-cv-01465-CFC, 1:22-cv-01467-CFC(mpb) |
|
Filing 22
ORDER, IT IS ORDERED that, on or before February 10, 2023, counsel for plaintiffs shall inform the court as to whether the need for coordinated discovery and/or Markman proceedings is anticipated as to these cases and, if so, when a joint scheduling conference might most efficiently be conducted. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 2/10/2023.) Signed by Judge Colm F. Connolly on 1/12/2023. Associated Cases: 1:22-cv-01461-CFC, 1:22-cv-01462-CFC, 1:22-cv-01465-CFC, 1:22-cv-01467-CFC(nmf)
|
| Pro Hac Vice Attorney Christina M. Baugh for Amicus Therapeutics US, LLC and Amicus Therapeutics, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:22-cv-01461-CFC, 1:22-cv-01462-CFC, 1:22-cv-01465-CFC, 1:22-cv-01467-CFC(mpb) |
| Pro Hac Vice Attorneys John W. Cox, Joshua M. Kalb, Mark C. Nelson, Anna Whitacre for Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:22-cv-01461-CFC, 1:22-cv-01462-CFC, 1:22-cv-01465-CFC, 1:22-cv-01467-CFC(twk) |
| Filing 21 NOTICE of Withdrawal of Megan C. Haney by Lupin Ltd., Lupin Pharmaceuticals, Inc. (Haney, Megan) |
| Filing 20 NOTICE of Appearance by David A. Bilson on behalf of Lupin Ltd., Lupin Pharmaceuticals, Inc. (Bilson, David) |
| Filing 19 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Lupin Limited for Lupin Pharmaceuticals, Inc. filed by Lupin Pharmaceuticals, Inc.. (Phillips, John) |
| Filing 18 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Lupin Ltd.. (Phillips, John) |
| Filing 17 ANSWER to #1 Complaint, Affirmative Defenses, COUNTERCLAIM against All Plaintiffs by Lupin Pharmaceuticals, Inc., Lupin Ltd..(Phillips, John) |
| Filing 16 MOTION for Pro Hac Vice Appearance of Attorney John W. Cox, Ph.D., Mark C. Nelson, Christina M. Baugh, Josh E. Ney, Ph.D., Heather B. Repicky, Joshua M. Kalb, Lauren Baker and Anna Whitacre - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Stover, Chad) |
|
SO ORDERED, re (11 in 1:22-cv-01462-CFC) (16 in 1:22-cv-01465-CFC) (11 in 1:22-cv-01461-CFC) (12 in 1:22-cv-01467-CFC) MOTION for Pro Hac Vice Appearance of Attorney John W. Cox, Ph.D., Mark C. Nelson, Christina M. Baugh, Josh E. Ney, Ph.D., Heather B. Repicky, Joshua M. Kalb, Lauren Baker and Anna Whitacre, filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC. Ordered by Judge Colm F. Connolly on 12/7/2022. Associated Cases: 1:22-cv-01461-CFC, 1:22-cv-01462-CFC, 1:22-cv-01465-CFC, 1:22-cv-01467-CFC(kmd)
|
| Pro Hac Vice Attorney Keith D. Parr, Nina Vachhani, Amy Lange Miller, Jacob C. Britz, and Jonathan B. Turpin for Lupin Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Filing 15 AFFIDAVIT of Service for Complaint served on counsel for Lupin Ltd. on 11/8/2022, filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Stover, Chad) |
| Filing 14 MOTION for Pro Hac Vice Appearance of Attorney Keith D. Parr, Nina Vachhani, Jonathan B. Turpin, Amy Lange Miller and Jacob C. Britz - filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Attachments: #1 Certification of Keith D. Parr, #2 Certification of Nina Vachhani, #3 Certification of Jonathan B. Turpin, #4 Certification of Amy Lange Miller, #5 Certification of Jacob C. Britz)(Haney, Megan) |
|
SO ORDERED, re #14 MOTION for Pro Hac Vice Appearance of Attorney Keith D. Parr, Nina Vachhani, Jonathan B. Turpin, Amy Lange Miller and Jacob C. Britz, filed by Lupin Ltd., Lupin Pharmaceuticals, Inc. Ordered by Judge Colm F. Connolly on 12/6/2022. (kmd)
|
|
Filing 13
SO ORDERED, re #12 Stipulation to Amend Caption, filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC. Signed by Judge Colm F. Connolly on 12/2/2022. (kmd)
|
| Filing 12 Joint STIPULATION and [Proposed] Order to Amend Caption by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Stover, Chad) |
| Filing 11 NOTICE of Voluntary Dismissal by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc. as to Springcare USA LLC d/b/a Spring Bio Solution (Stover, Chad) |
| Filing 10 NOTICE of Appearance by Megan C. Haney on behalf of Lupin Ltd., Lupin Pharmaceuticals, Inc. (Haney, Megan) |
|
SO ORDERED, re #9 STIPULATION TO EXTEND TIME move, answer, plead or otherwise respond to the Complaint to January 6, 2023, filed by Lupin Ltd., Lupin Pharmaceuticals, Inc. Reset Answer Deadlines: Lupin Ltd. answer due 1/6/2023; Lupin Pharmaceuticals, Inc. answer due 1/6/2023. Ordered by Judge Colm F. Connolly on 11/29/2022. (kmd)
|
| Filing 9 STIPULATION TO EXTEND TIME move, answer, plead or otherwise respond to the Complaint to January 6, 2023 - filed by Lupin Ltd., Lupin Pharmaceuticals, Inc.. (Phillips, John) |
| Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:22-cv-01461-CFC, 1:22-cv-01462-CFC, 1:22-cv-01465-CFC, 1:22-cv-01467-CFC (rjb) |
| Filing 8 SUMMONS Returned Executed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc..Lupin Pharmaceuticals, Inc. served on 11/8/2022, answer due 11/29/2022. (Stover, Chad) |
| Filing 7 Summons Issued as to Lupin Ltd. on 11/7/2022; Lupin Pharmaceuticals, Inc. on 11/7/2022; Springcare USA LLC on 11/7/2022. (Attachments: #1 Summons Forms - Unsigned Lupin Pharmaceuticals, Inc., #2 Summons Forms - Unsigned Springcare USA LLC d/b/a Spring Bio Solution)(lam) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Amicus Therapeutics, Inc.. (lam) Modified on 11/8/2022 (lam). |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Amicus Therapeutics, Inc. for Amicus Therapeutics US, LLC filed by Amicus Therapeutics US, LLC. (lam) (Main Document 5 replaced on 11/8/2022) (lam). |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) See Attachment. (lam) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: October 5, 2022. Date of Expiration of Patent: See Attachment.Thirty Month Stay Deadline: 2/10/2026. (lam) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lam) |
| Filing 1 COMPLAINT For Patent Infringement filed against Lupin Ltd., Lupin Pharmaceuticals, Inc., Springcare USA LLC ( Filing fee $ 402, receipt number ADEDC-4000504.) - filed by Amicus Therapeutics US, LLC, Amicus Therapeutics, Inc.. (Attachments: #1 Exhibit A-N, #2 Exhibit O-W, #3 Civil Cover Sheet)(lam) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
